A9528 Iodine i-131 iodide cap, dx

Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for A9528

Physician Fee Schedule (CY 2026, RVU26D)

Status C: contractor-priced by the MAC.

Payer policies and prior authorization for A9528

2 of 2 payer prior-auth lists that name A9528 require prior authorization or set conditions: Blue Cross and Blue Shield of Illinois, Blue Cross and Blue Shield of Texas.

PayerPlanStatePrior authConditionsSinceSource
Blue Cross and Blue Shield of IllinoisBlue Cross Community Health Plans (BCCHP), Illinois MedicaidILprior auth requiredCarelon-managedAug 1, 2025Illinois Medicaid Prior Authorization Code List, Effective 10/1/2026
Blue Cross and Blue Shield of TexasTexas PA exemption (gold card), outpatient, fully insuredTXprior auth requiredGold-card exemption availableJul 1, 2026BCBSTX Outpatient Prior Authorization Exemption Clinical Guidelines (max units, PA exempt date range)

Payer coverage policies that name A9528

A9528 appears in 1 coverage policy from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaTransthyretin-Mediated (ATTR) Amyloidosis (0939)listed, no stance (range A9510-A9568)Aug 10, 2026payer document

Recent prior-auth changes

  • Nov 1, 2025: PA added, Blue Cross and Blue Shield of Illinois

Medicaid fee-for-service

Prior authorization required or conditional in IN.

  • AZ: $0.01 (outpatient_hospital), effective Apr 1, 2025
  • KY: $0.00 (asc), effective Jan 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.